Oops – seems like the OpenPayments data is incompletely capturing the financial influence AI/ML vendors have over physicians and institutions. #medsky #MLsky www.evidencetriage.com/p/a-new-phys...

Manufacturers of >90% of FDA-listed #AI- and machine learning–enabled devices publicly disclosed no payments to clinicians or teaching hospitals from 2017-2023, but the $ amount of general payments doubled in that time frame. ja.ma/3VVS9WB

In @jama.com, we identify a blind spot for FDA-listed AI/ML devices 🤖🔍 Over 90% have no reported manufacturer payments to clinicians or hospitals in Open Payments (US disclosure database) As AI enters care, transparency can’t lag jamanetwork.com/journals/jam...

We're thrilled to announce the 2025–26 Schwartz Reisman Institute Graduate Fellows! 🎉 15 outstanding PhD students from @uoft.bsky.social will join our interdisciplinary community exploring how advanced technologies can better serve society. Meet them 👉 srinstitute.utoronto.ca/news/schswar...

Thrilled to be a 2025 @jama.com Editorial Fellow!

🚨70% of Canadian urology residents & faculty are dissatisfied with Competency-Based Medical Education. Introduced in 2018, CBME is causing stress, fatigue, and administrative burden. Our survey reveals key challenges. cuaj.ca/index.php/jo...

Very cool to see @thewonkologist.bsky.social comment on our recent JAMA study in this article. Good summary of our findings and reasons why more work is needed. www.oncologynewscentral.com/oncology/are...